.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
SPRINT-MIND examined whether intensive systolic blood-pressure control could reduce cognitive decline in adults at elevated cardiovascular risk. Although the primary endpoint of probable dementia was not significantly reduced, intensive treatment produced a statistically significant reduction in the risk of mild cognitive impairment and the combined outcome of mild cognitive impairment or dementia. The findings broaden the consequences of hypertension management beyond stroke, myocardial infarction and heart failure. For internists, the result supports careful attention to blood pressure across the life course while avoiding simplistic claims that “lower is always better” for every older patient. Individualized treatment should consider frailty, orthostatic symptoms, kidney function and polypharmacy. The study is especially relevant to patients with both cardiovascular and cognitive risk factors, because effective vascular prevention may have downstream neurologic benefits. It also reinforces the importance of accurate BP measurement and longitudinal follow-up rather than isolated clinic readings.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
SPRINT-MIND examined whether intensive systolic blood-pressure control could reduce cognitive decline in adults at elevated cardiovascular risk. Although the primary endpoint of probable dementia was not significantly reduced, intensive treatment produced a statistically significant reduction in the risk of mild cognitive impairment and the combined outcome of mild cognitive impairment or dementia. The findings broaden the consequences of hypertension management beyond stroke, myocardial infarction and heart failure. For internists, the result supports careful attention to blood pressure across the life course while avoiding simplistic claims that “lower is always better” for every older patient. Individualized treatment should consider frailty, orthostatic symptoms, kidney function and polypharmacy. The study is especially relevant to patients with both cardiovascular and cognitive risk factors, because effective vascular prevention may have downstream neurologic benefits. It also reinforces the importance of accurate BP measurement and longitudinal follow-up rather than isolated clinic readings.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
